Current Status of Pseudomonas aeruginosa Vaccine

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|14|11|951-959

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.14, Iss.11, 2013-11, pp. : 951-959

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis E vaccine: current status and future prospects

By Amini-Bavil-Olyaee Samad   Trautwein Christian   Tacke Frank  

Future Virology, Vol. 4, Iss. 2, 2009-03 ,pp. : 143-154

Future Medicine

Access to resources Recommend Favorite

Shigella Vaccine Development: Prospective Animal Models and Current Status

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 10, 2013-11 ,pp. : 903-912

Bentham Science Publishers

Access to resources Recommend Favorite

Overcoming antibacterial resistance of Pseudomonas aeruginosa

By  

Inpharma, Vol. 1, Iss. 1336, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

The Implication of Pseudomonas aeruginosa Biofilms in Infections

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 2, 2011-04 ,pp. : 141-157

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapies for Pseudomonas aeruginosa Pneumonia

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 11, Iss. 4, 2011-08 ,pp. : 389-394

Bentham Science Publishers

Access to resources Recommend Favorite